|
⚲
|
| Keyboard |
| Arch Venture Partners XII LLC | |
|---|---|
| Firm | Arch Venture Management LLC |
| Address | c/o Arch Venture Management Corporation 8755 W Higgins Road, Suite 1025 Chicago, IL 60631 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Arch Venture Management LLC | |||||
| Arch Venture Fund XII LP | 021-432243 | Director | 2,810.0 M of 2,910.0 M |
2,960.5 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metsera Inc MTSR
Common Stock
|
2025-11-13 | Disposed to issuer | 18,503,128 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-11-13 | Disposed to issuer | 8,313,680 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2025-10-27 | Buy | 1,915,700 | $2.61 | 4,999,977 |
|
Prime Medicine Inc PRME
Common Stock
|
2025-08-01 | Buy | 3,030,300 | $3.30 | 9,999,990 |
|
Metsera Inc MTSR
Series B Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 2,678,571 | ||
|
Metsera Inc MTSR
Series Seed Preferred Stock · derivative
|
2025-02-03 | Conversion | 19,933,333 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Conversion | 16,006,949 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Buy | 789,998 | $18.00 | 14,219,964 |
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Buy | 1,432,224 | $18.00 | 25,780,032 |
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Conversion | 7,523,682 | ||
|
Metsera Inc MTSR
Series B Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 2,678,571 | ||
|
Metsera Inc MTSR
Series A Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 15,000,000 | ||
|
Metsera Inc MTSR
Series A Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 15,000,000 | ||
|
Rapport Therapeutics Inc RAPP
Series A Preferred Stock · derivative
|
2024-06-10 | Conversion | 20,000,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Series B Preferred Stock · derivative
|
2024-06-10 | Conversion | 11,924,138 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2024-06-10 | Conversion | 3,728,738 | $0.00 | |
|
Prime Medicine Inc PRME
Common Stock
|
2024-02-15 | Buy | 3,200,000 | $6.25 | 20,000,000 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 1,176,593 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 703,061 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-11-14 | Buy | 3,357 | $11.98 | 40,217 |
| showing 20 of 48 most recent transactions | |||||